Company Profile

AARTI DRUGS LTD.

NSE : AARTIDRUGSBSE : 524348ISIN CODE : INE767A01016Industry : Pharmaceuticals & DrugsHouse : Aarti
BSE619.70-10.7 (-1.7 % )
PREV CLOSE (Rs.) 630.40
OPEN PRICE (Rs.) 625.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 8558
TODAY'S LOW / HIGH (Rs.)613.80 635.65
52 WK LOW / HIGH (Rs.)580 1025
NSE619.45 -11.3 (-1.79 % )
PREV CLOSE(Rs.) 630.75
OPEN PRICE (Rs.) 633.40
BID PRICE (QTY) 619.45 (230 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 188130
TODAY'S LOW / HIGH(Rs.) 613.30 633.40
52 WK LOW / HIGH (Rs.)580 1026.95

Financial ratio

Particulars Mar  2021 Mar  2020 Mar  2019 Mar  2018 Mar  2017
Operational & Financial Ratios          
   Earnings Per Share (Rs) 30.09 60.69 38.06 34.90 34.29
   CEPS(Rs) 35.44 20.40 14.03 12.97 12.60
   DPS(Rs) 2.50 2.00 1.00 1.00 1.00
   Book NAV/Share(Rs) 98.01 280.04 230.45 193.12 167.72
   Tax Rate(%) 24.01 23.69 31.50 33.89 29.49
Margin Ratios          
   Core EBITDA Margin(%) 20.44 14.70 13.51 15.99 14.79
   EBIT Margin(%) 18.34 12.33 11.18 12.90 12.11
   Pre Tax Margin(%) 17.13 10.26 8.39 9.86 9.01
   PAT Margin (%) 13.01 7.83 5.75 6.52 6.35
   Cash Profit Margin (%) 15.33 10.53 8.48 9.69 9.34
Performance Ratios          
   ROA(%) 16.78 9.33 6.31 6.38 7.13
   ROE(%) 35.81 23.65 17.97 19.24 21.60
   ROCE(%) 34.52 21.39 17.01 17.31 18.50
   Asset Turnover(x) 1.29 1.19 1.10 0.98 1.12
   Sales/Fixed Asset(x) 2.02 1.81 1.66 1.44 1.64
   Working Capital/Sales(x) 4.67 6.43 8.07 10.96 16.70
Efficiency Ratios          
   Fixed Capital/Sales(x) 0.50 0.55 0.60 0.70 0.61
   Receivable days 88.41 95.71 97.45 97.10 89.05
   Inventory Days 62.71 57.80 61.36 70.52 54.97
   Payable days 68.71 64.68 68.08 73.82 67.66
Valuation Parameters          
   PER(x) 23.09 2.08 16.83 14.52 16.79
   PCE(x) 19.61 6.20 11.41 9.76 11.42
   Price/Book(x) 7.09 1.81 2.78 2.62 3.43
   Yield(%) 0.36 0.40 0.16 0.20 0.17
   EV/Net Sales(x) 3.16 0.86 1.29 1.40 1.55
   EV/Core EBITDA(x) 15.31 5.81 9.43 8.56 9.50
   EV/EBIT(x) 17.23 6.96 11.53 10.66 11.85
   EV/CE(x) 3.86 0.98 1.38 1.25 1.55
   M Cap / Sales 3.01 0.65 0.97 0.96 1.15
Growth Ratio          
   Net Sales Growth(%) 19.31 15.71 25.52 4.05 4.85
   Core EBITDA Growth(%) 66.63 25.16 5.13 4.33 8.16
   EBIT Growth(%) 77.47 27.61 7.17 4.38 8.89
   PAT Growth(%) 98.30 57.54 9.05 0.62 19.03
   EPS Growth(%) -50.42 59.45 9.05 1.79 20.82
Financial Stability Ratios          
   Total Debt/Equity(x) 0.38 0.58 0.93 1.20 1.20
   Current Ratio(x) 1.78 1.45 1.33 1.19 1.16
   Quick Ratio(x) 1.08 0.93 0.91 0.74 0.73
   Interest Cover(x) 15.07 5.95 4.01 4.25 3.90
   Total Debt/Mcap(x) 0.05 0.32 0.34 0.46 0.35